Market Value7,560,766,669
Total Holdings78
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TNYA / Tenaya Therapeutics, Inc.
MGX / Metagenomi, Inc.
ANRO / Alto Neuroscience, Inc.
VXRT / Vaxart, Inc.
CRVO / CervoMed Inc.
SLDB / Solid Biosciences Inc.
AVTE / Aerovate Therapeutics, Inc.
ZURA / Zura Bio Limited
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
NKTX / Nkarta, Inc.
AXSM / Axsome Therapeutics, Inc.
MGNX / MacroGenics, Inc.
CMRX / Chimerix, Inc.
TARA / Protara Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
CCCC / C4 Therapeutics, Inc.
NUVL / Nuvalent, Inc.
LXEO / Lexeo Therapeutics, Inc.
INBX.V / Inhibrx, Inc.
RXRX / Recursion Pharmaceuticals, Inc.
BIIB / Biogen Inc.
ATXS / Astria Therapeutics, Inc.
SCLX / Scilex Holding Company
CLYM / Climb Bio, Inc.
PCSC / Perceptive Capital Solutions Corp
THRD / Third Harmonic Bio, Inc.
RNA / Avidity Biosciences, Inc.
MLYS / Mineralys Therapeutics, Inc.
CTKB / Cytek Biosciences, Inc.
RGLS / Regulus Therapeutics Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
WVE / Wave Life Sciences Ltd.
CGON / CG Oncology, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
LRMR / Larimar Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
EVH / Evolent Health, Inc.
FULC / Fulcrum Therapeutics, Inc.
TSHA / Taysha Gene Therapies, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
SERA / Sera Prognostics, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
INSM / Insmed Incorporated
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
GERN / Geron Corporation
LENZ / LENZ Therapeutics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
FDMT / 4D Molecular Therapeutics, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
CYBN / Cybin Inc.
CVAC / CureVac N.V.
HOWL / Werewolf Therapeutics, Inc.
PEPG / PepGen Inc.
SRZN / Surrozen, Inc.
ELVN / Enliven Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant
ETNB / 89bio, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
DYN / Dyne Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
APGE / Apogee Therapeutics, Inc.
ACET / Adicet Bio, Inc.
ITOS / iTeos Therapeutics, Inc.
GHRS / GH Research PLC
IMTX / Immatics N.V.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
NRIX / Nurix Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
ANTX / AN2 Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
EWTX / Edgewise Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
BOLD / Boundless Bio, Inc.
SPRY / ARS Pharmaceuticals, Inc.
RXST / RxSight, Inc.
UNCY / Unicycive Therapeutics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
ACLX / Arcellx, Inc.
TRML / Tourmaline Bio, Inc.
URGN / UroGen Pharma Ltd.
ARVN / Arvinas, Inc.
JANX / Janux Therapeutics, Inc.
ACRV / Acrivon Therapeutics, Inc.
VOR / Vor Biopharma Inc.